Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online July 15, 2011.
Article Versions
- You are currently viewing a previous version of this article (July 15, 2011 - 06:29).
- View the most recent version of this article
Copyright & Usage
© 2011 by Society of Nuclear Medicine
Author Information
- Christian Meyer zum Büschenfelde*,1,2,
- Ken Herrmann*,3,
- Tibor Schuster4,
- Hans Geinitz5,
- Rupert Langer6,
- Karin Becker6,
- Katja Ott7,
- Matthias Ebert8,
- Frank Zimmermann5,9,
- Helmut Friess3,
- Markus Schwaiger2,
- Christian Peschel1,
- Florian Lordick1,10,† and
- Bernd Joachim Krause†,3
- 13rd Department of Medicine (Haematology and Medical Oncology), Klinikum rechts der Isar, Technische Universität München, Munich, Germany
- 2Department of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
- 3Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
- 4Institute of Medical Statistics and Epidemiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
- 5Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
- 6Department of Pathology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
- 7Department of Surgery, University of Heidelberg, Heidelberg, Germany
- 82nd Department of Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
- 9Radioonkology Universitätsspital Basel, Basel, Switzerland; and
- 103rd Department of Medicine (Hematology and Medical Oncology), Clinic Braunschweig and Hannover Medical School, Braunschweig, Germany
- For correspondence or reprints contact: Christian Meyer zum Büschenfelde, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, D 81675 Munich, Germany. E-mail: christian.mzb{at}lrz.tum.de
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- Advances in diagnosis and management of cancer of the esophagus
- Histology-based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep Learning
- Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
- Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment: Secondary Analysis of a Randomized Trial for Resectable Stage IIIA/B Non-Small-Cell Lung Cancer
- Predictive Value of Positron Emission Tomography/Computed Tomography to Assess Early Treatment Response to Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade Without Chemotherapy for HER2-Positive Metastatic Breast Cancer: Are We Ready to Embrace This "Early Metabolic Look" Strategy?
- 18F-FLT PET Evaluation of Radiation Response
- Value of Functional Imaging by PET in Esophageal Cancer
- Locally Advanced Gastroesophageal Junction Tumor: A Treatment Dilemma
- Measuring Tumor Metabolism by 18F-FDG PET Predicts Outcome in a Multicenter Study: A Step Off in the Right Direction
- Critical Appraisal of Locoregional Failure and Systemic Disease Progression After Preoperative Chemoradiation of Esophageal Adenocarcinoma